title: New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
abstract: Hepatitis B virus (HBV) surface antigen (HBsAg) is considered to be the most important target for the diagnosis and immune prophylaxis of HBV infection. HBsAg-specific monoclonal antibodies (MAbs) are extensively used for studying the complex structure of the HBsAg, mapping the neutralizing epitopes and development of HBV diagnostic tests. However, the efficiency of anti-HBV binding strongly depends on the epitope structure and MAb capability to recognize different HBV variants. In the current study, 9 MAbs against yeast-expressed HBsAg of ayw2 serotype were generated and 7 of them were shown to recognize a linear epitope comprising amino acid (aa) residues 119-GPCRTCT-125 within the main antigenic "a" determinant of HBsAg. One MAb of the highest affinity (clone HB1) was selected for detailed cross-reactivity studies, generation of recombinant single-chain antibody (scFv) and molecular modelling of antibody-epitope interaction. The importance of each aa residue within the identified MAb epitope was determined by alanine substitution study that revealed aa residues C(121), T(123), C(124) and T(125) as essential for binding. These aa residues are highly conserved among HBV variants. In contrast, alanine substitution of G119, P120 and R122 had no or minor influence on the reactivity with the MAb. Certain aa residues at position 122 (either R or K) define different HBV serotypes (either d or y), therefore, the affinity of the MAb HB1 for the epitope with R122K substitution was determined to evaluate its diagnostic potential. The MAb recognized both epitope variants with high affinity. Sequence alignment of the MAb epitope within different HBV strains demonstrated that the shortest peptide recognized by the MAb 121-CR(K)TCT-125 is identical among different human HBV genotypes (HBV A-F, H) and monkey HBV species (HBVCP, HBVGO, HBVGB, WMHBV). In line with these data, the MAb HB1 was cross-reactive in Western blot with a large panel of antigens derived from different HBV genotypes. Recombinant scFv consisting of immunoglobulin VH and VL regions joined by a 20 aa-long linker was generated by cloning the respective cDNA sequences from hybridoma HB1. The recombinant scFv generated in Escherichia coli recognized the same epitope as the parental MAb HB1. Cloning of HB1 VH and VL regions allowed determination of their primary structure and subsequent computer modeling of antibody-epitope interaction. The generated molecular models of HB1 variable region with its target peptides were in accordance with experimental data showing the importance of certain aa residues in antibody binding. In conclusion, the current study describes new HBsAg-specific antibodies with HBV-neutralizing potency and a broad cross-reactivity against different HBV strains. The generated MAb HB1 will be of great value in diagnostic and research settings, while the recombinant HB1-derived scFv represents a promising "building block" for producing anti-HBV tools with a potential biopharmaceutical application.
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Indre
authors.initials: I
authors.lastname: Kucinskaite-Kodze
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Milda
authors.initials: M
authors.lastname: Pleckaityte
authors.affiliation: Institute of Medical Virology, Justus-Liebig University Giessen, National Reference Center for Hepatitis B and D Viruses, German Center for Infection Research (DZIF), Biomedical Research Center Seltersberg, Schubert-Str. 81, 35392 Giessen, Germany.
authors.forename: Corinna M
authors.initials: CM
authors.lastname: Bremer
authors.affiliation: Institute of Medical Virology, Justus-Liebig University Giessen, National Reference Center for Hepatitis B and D Viruses, German Center for Infection Research (DZIF), Biomedical Research Center Seltersberg, Schubert-Str. 81, 35392 Giessen, Germany.
authors.forename: Pia L
authors.initials: PL
authors.lastname: Seiz
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Milda
authors.initials: M
authors.lastname: Zilnyte
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Aiste
authors.initials: A
authors.lastname: Bulavaite
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Gitana
authors.initials: G
authors.lastname: Mickiene
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Gintautas
authors.initials: G
authors.lastname: Zvirblis
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.
authors.forename: Kestutis
authors.initials: K
authors.lastname: Sasnauskas
authors.affiliation: Institute of Medical Virology, Justus-Liebig University Giessen, National Reference Center for Hepatitis B and D Viruses, German Center for Infection Research (DZIF), Biomedical Research Center Seltersberg, Schubert-Str. 81, 35392 Giessen, Germany.
authors.forename: Dieter
authors.initials: D
authors.lastname: Glebe
authors.affiliation: Institute of Biotechnology, Dept. of Immunology and Cell Biology, Vilnius University, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania. Electronic address: aurelija.zvirbliene@bti.vu.lt.
authors.forename: Aurelija
authors.initials: A
authors.lastname: Zvirbliene
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000276:immunology; D057134:Antibodies, Neutralizing / Q000235:genetics / Q000276:immunology*; D018604:Epitope Mapping; D006509:Hepatitis B / Q000276:immunology* / Q000821:virology; D006510:Hepatitis B Antibodies / Q000235:genetics / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D006515:Hepatitis B virus / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data
chemical_list: D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens
keywords: Epitope mapping; HBsAg; Hepatitis B virus; Monoclonal antibodies; scFv